Our analyses reveal the prognostic value of ASPSCR1-TFE3 fusion and SCNAs for TFE3-tRCC, identify five molecular subsets with distinct transcriptional signatures. This evidence concerns the gene ASPSCR1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.